Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume 24, Issue 4, Pages 379-393
Publisher
Mary Ann Liebert Inc
Online
2009-08-21
DOI
10.1089/cbr.2009.0674
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Nanooncology
- (2014) K. K. Jain TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Application of Nanotechnology in Cancer
- (2014) Hirendra N. Banerjee et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Improving Tumor Uptake and Pharmacokinetics of64Cu-Labeled Cyclic RGD Peptide Dimers with Gly3and PEG4Linkers
- (2009) Jiyun Shi et al. BIOCONJUGATE CHEMISTRY
- Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects
- (2009) R. H. Kimura et al. CANCER RESEARCH
- 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
- (2009) Lihui Wei et al. NUCLEAR MEDICINE AND BIOLOGY
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
- (2008) Monty Liong et al. ACS Nano
- Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
- (2008) David E. Sosnovik et al. BASIC RESEARCH IN CARDIOLOGY
- Synthesis and Characterization of Core–Shell Star Copolymers for In Vivo PET Imaging Applications
- (2008) Ken-ichi Fukukawa et al. BIOMACROMOLECULES
- Facile, Efficient Approach to Accomplish Tunable Chemistries and Variable Biodistributions for Shell Cross-Linked Nanoparticles
- (2008) Guorong Sun et al. BIOMACROMOLECULES
- A novel side-bridged hybrid phosphonate/acetate pendant cyclam: Synthesis, characterization, and 64Cu small animal PET imaging
- (2008) C. Andrew Boswell et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Imaging of integrin αvβ3 expression
- (2008) Ambros J. Beer et al. CANCER AND METASTASIS REVIEWS
- Receptor-Binding, Biodistribution, and Metabolism Studies of 64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors
- (2008) Wen Ping Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Spectroelectrochemical and Computational Studies on the Mechanism of Hypoxia Selectivity of Copper Radiopharmaceuticals
- (2008) Jason P. Holland et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthesis of [2H]- and [13C]-labeled pyronaridine tetraphosphate-an antimalarial drug
- (2008) Sang Hyun Park et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
- (2008) F. Dehdashti et al. JOURNAL OF NUCLEAR MEDICINE
- An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix
- (2008) J. S. Lewis et al. JOURNAL OF NUCLEAR MEDICINE
- Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor-Positive Tumors
- (2008) T. J. Wadas et al. JOURNAL OF NUCLEAR MEDICINE
- PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles
- (2008) H.-Y. Lee et al. JOURNAL OF NUCLEAR MEDICINE
- Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer
- (2008) Carmen S. Dence et al. NUCLEAR MEDICINE AND BIOLOGY
- Noninvasive molecular imaging of small living subjects using Raman spectroscopy
- (2008) S. Keren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More